ctrl K

Price Alert

Innate Pharma S.A. (IPHA)

NASDAQ: IPHA · Real-Time Price · USD

2.11

-0.07 (-3.21%)

At close: Aug 15, 2025, 3:59 PM

2.12

0.47%

After-hours: Aug 15, 2025, 04:00 PM EDT

Innate Pharma S.A. Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	66.4M	70.61M	84.22M	103.76M
Short-Term Investments	14.37M	21.85M	17.26M	16.08M
Long-Term Investments	10.28M	9.8M	35.12M	39.88M
Other Long-Term Assets	9.9M	1.64M	14.25M	29.97M
Receivables	1.64M	15.23M	3.08M	846K
Inventory	n/a	n/a	-2K	-4.95M
Other Current Assets	n/a	34.63M	30.59M	14.99M
Total Current Assets	85.74M	148.01M	139.83M	138.26M
Property-Plant & Equipment	5.13M	6.32M	8.54M	10.17M
Goodwill & Intangibles	n/a	416K	1.56M	44.19M
Total Long-Term Assets	25.32M	27.18M	68.03M	129.24M
Total Assets	111.06M	184.19M	207.86M	267.5M
Account Payables	7.92M	8.56M	13.66M	14.73M
Deferred Revenue	616K	5.87M	6.56M	12.5M
Short-Term Debt	8.44M	8.45M	1.26M	29.94M
Other Current Liabilities	7.65M	7.82M	19.02M	21.91M
Total Current Liabilities	32.98M	39.64M	41.34M	79.89M
Long-Term Debt	22.18M	30.61M	38.93M	11.49M
Other Long-Term Liabilities	44.13M	39.07M	55.74M	36.23M
Total Long-Term Liabilities	69.24M	92.66M	112.37M	80.17M
Total Liabilities	102.22M	132.29M	153.71M	160.06M
Total Debt	31M	39.89M	42.25M	44.25M
Common Stock	4.19M	4.04M	4.01M	3.98M
Retained Earnings	-386.36M	-336.89M	-330.32M	-272.21M
Comprehensive Income	27K	495K	819K	456K
Shareholders Equity	8.83M	51.9M	54.15M	107.44M
Total Investments	24.66M	31.65M	52.38M	55.96M